1. danieltorres20
2. nealbangia
1.nealbangia 02/08/2018
Reports Q2 EPS loss of $0.16 and revenue of $0.36M (-97.9% Y/Y)
2.danieltorres20 01/11/2018
More good news - orphan drug
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW